U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Jun 26 18:17:46 UTC 2021
Edited
by admin
on Sat Jun 26 18:17:46 UTC 2021
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
3JB47N2Q2P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NATALIZUMAB
EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
ANTEGREN
Common Name English
NATALIZUMAB [MI]
Common Name English
NATALIZUMAB [PURPLE BOOK, CDER]
Common Name English
NATALIZUMAB [WHO-DD]
Common Name English
AN100226M
Code English
NATALIZUMAB [INN]
Common Name English
NATALIZUMAB ELAN PHARMA
Brand Name English
NATALIZUMAB [EMA EPAR]
Common Name English
TYSABRI
Brand Name English
NATALIZUMAB [VANDF]
Common Name English
ANTEGRAN
Code English
NATALIZUMAB [MART.]
Common Name English
NATALIZUMAB [USAN]
Common Name English
IMMUNOGLOBULIN G4 (HUMAN-MOUSE MONOCLONAL AN100226 4-CHAIN ANTI-HUMAN INTEGRIN 4), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL AN100226 LIGHT CHAIN, DIMER
Common Name English
NATALIZUMAB [JAN]
Common Name English
IMMUNOGLOBULIN G4 (HUMAN-MOUSE MONOCLONAL AN100226 4-CHAIN ANTI-HUMAN INTEGRIN 4), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL AN100226 LIGHT CHAIN, DIMER
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
WHO-ATC L04AA23
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
EMA ASSESSMENT REPORTS TYSABRI (AUTHORIZED: MULTIPLE SCLEROSIS)
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
NDF-RT N0000175774
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
LIVERTOX 670
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
WHO-VATC QL04AA23
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
NDF-RT N0000175775
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
EMA ASSESSMENT REPORTS NATALIZUMAB ELAN PHARMA (REFUSED: CROHN DISEASE)
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
NCI_THESAURUS C129822
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
Code System Code Type Description
IUPHAR
6591
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
MERCK INDEX
M7778
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY Merck Index
DRUG CENTRAL
4970
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
CAS
189261-10-7
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
DRUG BANK
DB00108
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
WIKIPEDIA
NATALIZUMAB
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
RXCUI
354770
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY RxNorm
HSDB
8174
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
ChEMBL
CHEMBL1201607
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
INN
7716
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
MESH
C469407
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
FDA UNII
3JB47N2Q2P
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
LACTMED
Natalizumab
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
NCI_THESAURUS
C77862
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
EVMPD
SUB22282
Created by admin on Sat Jun 26 18:17:46 UTC 2021 , Edited by admin on Sat Jun 26 18:17:46 UTC 2021
PRIMARY
From To
1_22 1_96
1_137 3_213
1_150 1_206
1_229 2_229
1_232 2_232
1_264 1_324
1_370 1_428
2_22 2_96
2_137 4_213
2_150 2_206
2_264 2_324
2_370 2_428
3_23 3_88
3_133 3_193
4_23 4_88
4_133 4_193
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
MOL_WEIGHT:NON-GLYCOSYLATED(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL